Cargando…

Concentrations of bile acid precursors in cerebrospinal fluid of Alzheimer's disease patients

Using liquid chromatography – mass spectrometry in combination with derivatisation chemistry we profiled the oxysterol and cholestenoic acid content of cerebrospinal fluid from patients with Alzheimer's disease (n = 21), vascular dementia (n = 11), other neurodegenerative diseases (n = 15, Lewy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Griffiths, William J., Abdel-Khalik, Jonas, Yutuc, Eylan, Roman, Gustavo, Warner, Margaret, Gustafsson, Jan-Åke, Wang, Yuqin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597949/ https://www.ncbi.nlm.nih.gov/pubmed/30578919 http://dx.doi.org/10.1016/j.freeradbiomed.2018.12.020

Ejemplares similares

Developing an Enzyme-Assisted Derivatization Method for Analysis of C(27) Bile Alcohols and Acids by Electrospray Ionization-Mass Spectrometry
por: Abdel-Khalik, Jonas, et al.
Publicado: (2019)

Defective cholesterol metabolism in amyotrophic lateral sclerosis
por: Abdel-Khalik, Jonas, et al.
Publicado: (2017)

Reduced Plasma Levels of 25-Hydroxycholesterol and Increased Cerebrospinal Fluid Levels of Bile Acid Precursors in Multiple Sclerosis Patients
por: Crick, Peter J., et al.
Publicado: (2016)

Identification of 7α,24-dihydroxy-3-oxocholest-4-en-26-oic and 7α,25-dihydroxy-3-oxocholest-4-en-26-oic acids in human cerebrospinal fluid and plasma
por: Abdel-Khalik, Jonas, et al.
Publicado: (2018)

Current trends in oxysterol research
por: Griffiths, William J., et al.
Publicado: (2016)

The Cerebrospinal Fluid Profile of Cholesterol Metabolites in Parkinson’s Disease and Their Association With Disease State and Clinical Features
por: Griffiths, William J., et al.
Publicado: (2021)

Charge-tagging liquid chromatography–mass spectrometry methodology targeting oxysterol diastereoisomers
por: Griffiths, William J., et al.
Publicado: (2017)

Cholesterolomics: An update
por: Griffiths, William J., et al.
Publicado: (2017)

Formation and metabolism of oxysterols and cholestenoic acids found in the mouse circulation: Lessons learnt from deuterium-enrichment experiments and the CYP46A1 transgenic mouse
por: Crick, Peter J., et al.
Publicado: (2019)

Cholesterol metabolism pathways – are the intermediates more important than the products?
por: Wang, Yuqin, et al.
Publicado: (2021)

Identification of unusual oxysterols and bile acids with 7-oxo or 3β,5α,6β-trihydroxy functions in human plasma by charge-tagging mass spectrometry with multistage fragmentation
por: Griffiths, William J., et al.
Publicado: (2018)

Metabolic profiling in serum, cerebrospinal fluid, and brain of patients with cerebrotendinous xanthomatosis
por: Höflinger, Philip, et al.
Publicado: (2021)

Additional pathways of sterol metabolism: Evidence from analysis of Cyp27a1−/− mouse brain and plasma
por: Griffiths, William J., et al.
Publicado: (2019)

Bile acid biosynthesis in Smith-Lemli-Opitz syndrome bypassing cholesterol: Potential importance of pathway intermediates
por: Abdel-Khalik, Jonas, et al.
Publicado: (2021)

24(S),25-Epoxycholesterol and cholesterol 24S-hydroxylase (CYP46A1) overexpression promote midbrain dopaminergic neurogenesis in vivo
por: Theofilopoulos, Spyridon, et al.
Publicado: (2019)

Deep mining of oxysterols and cholestenoic acids in human plasma and cerebrospinal fluid: Quantification using isotope dilution mass spectrometry
por: Yutuc, Eylan, et al.
Publicado: (2021)

Identification of unusual oxysterols biosynthesised in human pregnancy by charge-tagging and liquid chromatography - mass spectrometry
por: Dickson, Alison L., et al.
Publicado: (2022)

Metabolism of Non-Enzymatically Derived Oxysterols: Clues from sterol metabolic disorders()()
por: Griffiths, William J., et al.
Publicado: (2019)

HSD3B1 is an oxysterol 3β-hydroxysteroid dehydrogenase in human placenta
por: Dickson, Alison, et al.
Publicado: (2023)

Heteromers of amyloid precursor protein in cerebrospinal fluid
por: Cuchillo-Ibañez, Inmaculada, et al.
Publicado: (2015)

Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease
por: Heslegrave, Amanda, et al.
Publicado: (2016)

Reduction of Glycolysis Intermediate Concentrations in the Cerebrospinal Fluid of Alzheimer’s Disease Patients
por: Bergau, Nick, et al.
Publicado: (2019)

C-terminal fragments of the amyloid precursor protein in cerebrospinal fluid as potential biomarkers for Alzheimer disease
por: García-Ayllón, María-Salud, et al.
Publicado: (2017)

Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease
por: Khoonsari, Payam Emami, et al.
Publicado: (2016)

Can agrin cerebrospinal fluid concentration be used as an early biomarker for Alzheimer's disease?
por: Del Campo Milan, Marta, et al.
Publicado: (2015)

Quantification of Bile Acids in Cerebrospinal Fluid: Results of an Observational Trial
por: Harnisch, Lars-Olav, et al.
Publicado: (2023)

The oxysterol and cholestenoic acid profile of mouse cerebrospinal fluid
por: Crick, Peter J., et al.
Publicado: (2015)

Cerebrospinal Fluid Protein Concentrations in Hydrocephalus
por: Wilhelmy, Florian, et al.
Publicado: (2023)

Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer's disease
por: Dhiman, Kunal, et al.
Publicado: (2020)

Cerebrospinal Fluid EV Concentration and Size Are Altered in Alzheimer’s Disease and Dementia with Lewy Bodies
por: Longobardi, Antonio, et al.
Publicado: (2022)

Mining for Oxysterols in Cyp7b1(−/−) Mouse Brain and Plasma: Relevance to Spastic Paraplegia Type 5
por: Meljon, Anna, et al.
Publicado: (2019)

Gene expression identifies metabolic and functional differences between intramuscular and subcutaneous adipocytes in cattle
por: Hudson, Nicholas J., et al.
Publicado: (2020)

The Concentration of Memantine in the Cerebrospinal Fluid of Alzheimer’s Disease Patients and Its Consequence to Oxidative Stress Biomarkers
por: Valis, Martin, et al.
Publicado: (2019)

Normal cerebrospinal fluid concentrations of PDGFRβ in patients with cerebral amyloid angiopathy and Alzheimer's disease
por: De Kort, Anna M., et al.
Publicado: (2021)

Metabolite Profiling of Alzheimer's Disease Cerebrospinal Fluid
por: Czech, Christian, et al.
Publicado: (2012)

Alzheimer disease pathology and the cerebrospinal fluid proteome
por: Dayon, Loïc, et al.
Publicado: (2018)

Cerebrospinal fluid in Alzheimer's: A precious tool
por: Parnetti, Lucilla, et al.
Publicado: (2016)

Tau oligomers in cerebrospinal fluid in Alzheimer's disease
por: Sengupta, Urmi, et al.
Publicado: (2017)

The concentration of desmethylmisonidazole in human tumours and in cerebrospinal fluid.
por: Dische, S., et al.
Publicado: (1981)

Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid
por: Selnes, Per, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_s3dmiaf3gvsdm7c1s6fbafhbik